BRIEF published on 06/05/2025 at 10:05, 11 months 1 day ago Eckert & Ziegler Expands with Approval of Illuccix® in Germany Gallium-68 Nuclear Medicine Prostate Cancer Illuccix® PSMA-PET Imaging
PRESS RELEASE published on 06/05/2025 at 10:00, 11 months 1 day ago Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany Eckert & Ziegler announces the approval of Illuccix® PSMA-PET Imaging Agent in Germany, expanding its nuclear medicine portfolio and partnership with Telix Pharmaceuticals Eckert & Ziegler Germany Approval Illuccix PSMA-PET
BRIEF published on 05/30/2025 at 10:05, 11 months 7 days ago Eckert & Ziegler Hosts Successful Boston Radionuclide Theranostics Forum Precision Oncology Industry Collaboration Radiopharmaceuticals Theranostics Forum Event Insights
BRIEF published on 05/30/2025 at 10:05, 11 months 7 days ago Eckert & Ziegler organise avec succès le Boston Radionuclide Theranostics Forum Oncologie De Précision Produits Radiopharmaceutiques Collaboration Industrielle Forum Théranostique Informations Sur Les Événements
PRESS RELEASE published on 05/30/2025 at 10:00, 11 months 7 days ago Eckert & Ziegler Organizes Third Boston Radionuclide Theranostics Forum Eckert & Ziegler successfully completes the 3rd annual Boston Radionuclide Theranostics Forum, gathering key leaders to discuss radionuclides in precision oncology Innovation Eckert & Ziegler Precision Oncology Radiopharmaceuticals Boston Radionuclide Theranostics Forum
BRIEF published on 05/23/2025 at 10:05, 11 months 14 days ago Eckert & Ziegler reçoit à nouveau un prestigieux prix de gestion Eckert & Ziegler Isotopes Médecine Nucléaire Sociétés Les Mieux Gérées Deloitte Privé
BRIEF published on 05/23/2025 at 10:05, 11 months 14 days ago Eckert & Ziegler Receives Prestigious Management Award Again Eckert & Ziegler Nuclear Medicine Best Managed Companies Deloitte Private Isotopes
PRESS RELEASE published on 05/23/2025 at 10:00, 11 months 14 days ago Eckert & Ziegler Wins “Best Managed Companies Award” for the Second Time Eckert & Ziegler SE wins the 'Best Managed Companies Award' for the second time, recognizing their excellence in strategy, productivity, innovation, culture, finance, and governance Eckert & Ziegler SE Nuclear Medicine Best Managed Companies Award Deloitte Private UBS
BRIEF published on 05/13/2025 at 07:50, 11 months 25 days ago Eckert & Ziegler Reports Q1 2025 Revenue Growth and Upholds Yearly Outlook Revenue Growth Medical Segment Isotope Products 2025 Forecast Q1 2025 Earnings
BRIEF published on 05/13/2025 at 07:50, 11 months 25 days ago Eckert & Ziegler annonce une croissance de son chiffre d'affaires au premier trimestre 2025 et maintient ses perspectives annuelles Croissance Des Revenus Secteur Médical Produits Isotopiques Prévisions Pour 2025 Résultats Du Premier Trimestre 2025
Published on 05/07/2026 at 05:40, 2 hours 46 minutes ago New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 6 hours 26 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 8 hours 56 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 9 hours 21 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 9 hours 26 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/07/2026 at 08:05, 21 minutes ago Hyundai Mobis Develops Power Electric Systems Ready to All EV Models
Published on 05/07/2026 at 08:05, 21 minutes ago Nota AI Signs AI Optimization Technology Supply and Strategic Partnership Agreement with Mobilint Accelerating Commercialization of On-Device AI on Domestic NPU Infrastructure
Published on 05/07/2026 at 08:00, 26 minutes ago Financial results Q1 2026 – Strong, profitable growth
Published on 05/07/2026 at 08:00, 26 minutes ago AIXTRON supplied Planetary GaN MOCVD Systems to Renesas for High-Volume Manufacturing Expansion
Published on 05/07/2026 at 08:00, 26 minutes ago Pentixapharm Reports First Quarter 2026 Results and Highlights Clinical and Regulatory Momentum
Published on 05/06/2026 at 18:00, 14 hours 26 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 14 hours 26 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 14 hours 26 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
